| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |